Forhet about Capital, and BOT said they have enough for next stage of marketing and sales
Don't forget BOT is getting revenue from Japans sales. Plus they'll market in Korea in 2025.
And they have acne and rosacea bye pipeline.
I don't want TO and are happy to sit on my shares and hope to get divvys down the track
And BOT bought out Royalties so no more debt/expense, fast track was paid out in full so next Quarterly balance should be very healthy
Ann: FDA Confirms Approach to Sofdra NDA Resubmission, page-80
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.3¢ |
Change
0.003(0.66%) |
Mkt cap ! $698.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.068M | 2.805M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 560285 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 460196 | 16 |
View Market Depth
| Last trade - 14.39pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |